Indonesia Medication Assisted Therapy (MAT) Market to 2032
Overview
The Indonesia Medication Assisted Therapy (MAT) Market is expected to reach a 101.32 by 2032 and is projected to grow at a CAGR of 10.37% from 2025 to 2032.
Revenue, 2024 ()
60.32
Forecast, 2032 ()
101.32
CAGR, 2024 - 2032
10.37%
Report Coverage
Indonesia
Indonesia Medication Assisted Therapy (MAT) Market 2018-2032
Indonesia Medication Assisted Therapy (MAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 60.32
- Projected Market Size (2032): 101.32
- CAGR (2025-2032): 10.37%
Key Findings of Indonesia Medication Assisted Therapy (MAT) Market
- The Indonesia Medication Assisted Therapy (MAT) Market was valued at 60.32 in 2024.
- The Indonesia Medication Assisted Therapy (MAT) Market is likely to grow at a CAGR of 10.37% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Adults in Population Type Segment accounted for the largest share of the market with a revenue of 56.80
- The fastest growing segment Buprenorphine and Naloxone in Products Segment grew Fastest with a CAGR of 12.97% during the forecast period from 2024 to 2032.
Indonesia Medication Assisted Therapy (MAT) Market Scope
Indonesia Medication Assisted Therapy (MAT) Market Segmentation & Scope
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Drug Type
- Branded
- Generics
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Indonesia Medication Assisted Therapy (MAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in |
| Market Value in 2024 | 60.32 |
| Market Value in 2032 | 101.32 |
| CAGR (2025-2032) | 10.37% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Dosage Form,Route of Administration,Drug Type,Population Type,End User,Type,Products,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Indonesia, leading in terms of revenue 60.32 in 2024
- Key Country: Indonesia, leading in terms of revenue with value of 60.32 in 2024.
Segments and Scope
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By Dosage Form
- Immediate Release is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 19.84 in the year 2024.
- Immediate Release is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.67 % in forecast period 2025-2032.
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By Route of Administration
- Oral is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 19.21 in the year 2024.
- Oral is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.78 % in forecast period 2025-2032.
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By Drug Type
- Generics is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 30.41 in the year 2024.
- Generics is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.24 % in forecast period 2025-2032.
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By Population Type
- Adults is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 56.80 in the year 2024.
- Adults is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 10.48 % in forecast period 2025-2032.
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By End User
- Rehabilitation Clinics is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 27.52 in the year 2024.
- Rehabilitation Clinics is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.44 % in forecast period 2025-2032.
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By Type
- Medication is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 33.38 in the year 2024.
- Medication is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.07 % in forecast period 2025-2032.
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By Products
- Buprenorphine and Naloxone is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 8.03 in the year 2024.
- Buprenorphine and Naloxone is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 12.97 % in forecast period 2025-2032.
-
Indonesia Medication Assisted Therapy (MAT) Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a revenue of 18.67 in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Indonesia Medication Assisted Therapy (MAT) Market to 2032 with a Growth rate of 11.85 % in forecast period 2025-2032.
Indonesia Medication Assisted Therapy (MAT) Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Indivior PLC | |||
| Mallinckrodt | |||
| Sun Pharmaceutical Industries Ltd. | |||
| Teva Pharmaceutical Industries Ltd. | |||
Indonesia Medication Assisted Therapy (MAT) Market Geographical Sales Distribution, 2018-2032
Indonesia Medication Assisted Therapy (MAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Indonesia Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Dosage Form,Route of Administration,Drug Type,Population Type,End User,Type,Products,Distribution Channel.
Indonesia Medication Assisted Therapy (MAT) Market was valued at USD 60.32(Revenue in ) in 2020.
Indonesia Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 10.37% during the forecast period of 2024 to 2032.
The Adults segment is expected to dominate the Indonesia Medication Assisted Therapy (MAT) Market, holding a largest market share of 56.80 in 2024
Coming Soon....
Indonesia Medication Assisted Therapy (MAT) Market Scope
Indonesia Medication Assisted Therapy (MAT) Market Segmentation & Scope
Dosage Form
- Extented Release
- Immediate Release
Route of Administration
- Others
- Parenteral
- Oral
Drug Type
- Branded
- Generics
Population Type
- Teenage
- Adults
End User
- Others
- Homecare
- Speciality Centers
- Hospitals
- Rehabilitation Clinics
Type
- Therapy
- Medication
Products
- Acamprosate
- Disulfarm
- Naloxone
- Metadone
- Buprenorphine
- Naltrexone
- Buprenorphine and Naloxone
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Direct Tender
- Hospital Pharmacy
Frequently Asked Questions
The Indonesia Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Dosage Form,Route of Administration,Drug Type,Population Type,End User,Type,Products,Distribution Channel.
Indonesia Medication Assisted Therapy (MAT) Market was valued at USD 60.32(Revenue in ) in 2020.
Indonesia Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 10.37% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Medication Assisted Therapy (MAT) Market for final year is USD 101.32 ().
Indonesia Medication Assisted Therapy (MAT) Market Company Profiling
Frequently Asked Questions
The Indonesia Medication Assisted Therapy (MAT) Market is segmented based on Segmentation Dosage Form,Route of Administration,Drug Type,Population Type,End User,Type,Products,Distribution Channel.
Indonesia Medication Assisted Therapy (MAT) Market was valued at USD 60.32(Revenue in ) in 2020.
Indonesia Medication Assisted Therapy (MAT) Market is projected to grow at a CAGR of 10.37% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Medication Assisted Therapy (MAT) Market for final year is USD 101.32 ().
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.